• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-TRAF4

TRAF4 Monoclonal Antibody for WB, IHC, IF/ICC, Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, porc

Applications

WB, IHC, IF/ICC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

2C9A11

N° de cat : 66755-1-PBS

Synonymes

2C9A11, CART1, Cysteine-rich domain associated with RING and Traf domains protein 1, EC:2.3.2.27, MLN 62



Informations sur le produit

66755-1-PBS cible TRAF4 dans les applications de WB, IHC, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, porc

Réactivité Humain, porc
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène TRAF4 Protéine recombinante Ag27221
Nom complet TNF receptor-associated factor 4
Masse moléculaire calculée 54 kDa
Poids moléculaire observé 50-54 kDa
Numéro d’acquisition GenBankBC001769
Symbole du gène TRAF4
Identification du gène (NCBI) 9618
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

The tumor necrosis factor receptor-associated factor (TRAF) family, consisting of seven members (TRAF1-7), is a group of signaling adaptors which participate in various signaling pathways through binding of the tumor necrosis factor receptor superfamily. As one of the important member of TRAF family proteins, TRAF4 was initially isolated from breast carcinomas and identified as the first member of the TRAF family to be up-regulated in human carcinomas. TRAF4 is required during embryogenesis in key biological processes including the formation of the trachea, the development of the axial skeleton, and the closure of the neural tube. TRAF4 deficiency leads to severe developmental alterations.

{{ptg:RelatedPrimaryAntibodies}}